Sida 1 från 39 resultat
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to certain peptides and to methods and pharmaceutical compositions incorporating such peptides, for treating mammals to control appetite and obesity.
2. Description of the Prior Art
Obesity is a well established
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to certain peptides and to methods and pharmaceutical compositions incorporating such peptides, for treating mammals to control appetite and obesity.
2. Description of the Prior Art
Obesity is a well established
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the US national stage of Application No. PCT/EP2007/061289, filed Oct. 22, 2007, which application claims priority from EP 06122820.1 filed Oct. 24, 2006.
The present invention is concerned with novel tetrahydro-naphthalene-1-carboxylic
CROSS REFERENCE TO RELATED APPLICATIONS
This application is the US national stage of Application No. PCT/EP2007/061286, filed Oct. 22, 2007, which application claims priority from EP 06122817.7 filed Oct. 24, 2006.
The present invention is concerned with novel piperidine or piperazine substituted
CROSS-REFERENCES TO RELATED APPLICATION
This patent application claims the benefit of priority under 35 U.S.C. .sctn.119 from Korean Patent Application No. 10-2008-0033284 filed Apr. 10, 2008, the contents of which are incorporated herein by reference.
TECHNICAL FIELD
The present disclosure relates
TECHNICAL FIELD
The present invention relates to a carboxylic acid derivative and a peroxisome proliferator activated receptor regulator containing carboxylic acid derivative as active ingredient.
More particularly, the present invention relates to a compound of the formula ##STR2##
(wherein, all
TECHNICAL FIELD
The present invention relates to a carboxylic acid derivative and a peroxisome proliferator activated receptor regulator containing carboxylic acid derivative as active ingredient.
More particularly, the present invention relates to a peroxisome proliferator activated regulator
TECHNICAL FIELD
The present invention relates to a carboxylic acid derivative and a peroxisome proliferator activated receptor regulator containing carboxylic acid derivative as active ingredient.
More particularly, the present invention relates to a compound of the formula (I)
##STR00002##
TECHNICAL FIELD
The present invention relates to a carboxylic acid derivative and a peroxisome proliferator activated receptor regulator containing carboxylic acid derivative as active ingredient.
More particularly, the present invention relates to a peroxisome proliferator activated regulator
FIELD OF THE INVENTION
This invention relates to compounds that inhibit the secretion of apolipoprotein B, and to methods of treating and/or preventing atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia,
FIELD OF THE INVENTION
This invention relates to compounds that inhibit the secretion of apolipoprotein B, and to methods of treating and/or preventing atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia,
BACKGROUND OF THE INVENTION
Human obesity or overweight is a recognized health problem. The accumulation or maintenance of body fat bears a direct relationship to caloric intake. Most weight control programs involve some restriction or alteration of the diet. However, there have also been various
FIELD OF INVENTION
The present invention relates to novel N-substituted azaheterocyclic compounds in which a substituted alkyl chain forms part of the N-substituent or salts thereof, to methods for their preparation, to compositions containing them, to the use of the compounds for preparing
FIELD OF INVENTION
The present invention relates to novel N-substituted azaheterocyclic compounds in which a substituted alkyl chain forms part of the N-substituent or salts thereof, to methods for their preparation, to compositions containing them, to the use of the compounds for preparing
BACKGROUND OF THE INVENTION
The present invention relates to novel thyroid receptor ligands and, more preferably, relates to indole carboxylic acids, and derivatives thereof, which are useful in the treatment of obesity, overweight condition, hyperlipidemia, glaucoma, cardiac arrhythmias, skin